СПИСОК ЛИТЕРАТУРЫ
Бикбов Б.Т., Томилина Н.А. Заместительная терапия больных с хронической почечной недостаточностю методами перитонеального диализа и трансплантации почки в Российской Федерации в 1998-2011 г. (отчёт по данным Российского регистра заместительной почечной терапии. Часть вторая) // Нефрология и диализ. – 2014. - №2. - С. 192-227.
Данович Г.М. Трансплантация почки / Пер. с англ. под ред. Я.Г. Мойсюка. – М.: ГЭОТАР-Медиа, 2013. – 848 с.
Прокопенко Е.И., Щербакова Е.О., Ватазин А.В. и др. Результаты профилактики цитомегаловирусной инфекции валганцикловиром у пациентов с трансплантированной почкой // Клиническая нефрология. 2013. - №5. С. 37-41.
Томилина Н.А., Прокопенко Е.И., Мойсюк Я.Г., Ким И.Г. Инфекционные осложнения после трансплантации почки / Инфекции в трансплантологии // Под ред. С.В. Готье. – М. – Тверь: ООО «Издательство «Триада», 2010. – С.53-146.
Трансплантология. Фармакотерапия без ошибок. Руководство для врачей / Под ред. С.В. Готье, Я.Г. Мойсюка. – М.: Е-ното, 2014. – 432 с.
Brennan D.C., Agha I., Bohl D.L. et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582–594.
Chenhsu R.Y., Loong C.C., Chou M.H. et al. Renal allograft dysfunction associated with rifampin-tacrolimus interaction // Ann Pharmacother. 2000. Vol.1. P. 27-31.
Cohn J., Blumberg E.A. Immunization for renal transplant candidates and recipients // Nature Clin Practice Nephrology. 2009. Vol. 5. P. 46-53.
Colomba C., Antinori S. Fungal infections in transplantation patients // Recenti Prog Med. 2003. Vol. 94(11). P. 516–528.
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. European best practice guidelines for renal transplantation. IV.7.2. Late infections. Tuberculosis // Nephrol Dial Transplant. 2002. Vol. 17 (Suppl 4). P. 39–43.
Epstein-Barr virus and lymphoproliferative disorders after transplantation // Am J Transplant. 2004. Vol. 4(Suppl 10). P. 59-65.
Ergun I., Ekmekci Y., Sengul S. et al. Mycobacterium tuberculosis infection in renal transplant recipients // Transplant Proc. 2006. Vol. 38. P. 1344–1345.
Fabrizi F., Martin P., Dixit V. et al. HBsAg seropositive status and survival after renal transplantation: Meta-analysis of observational studies // Am J Transplant. 2005. Vol. 5. P. 2913–2921.
Fishman J.A. Infections in organ-transplant recipients // N Engl J Med. 2007.
Vol. 357. P. 2601-2614.
Fox B.C., Sollinger H.W., Belzer F.O. et al. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: Clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis // Am J Med. 1990. Vol. 89. P. 255–274.
Franco A., Jiménez L., Sillero C. et al. Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience // Nefrologia. 2010. Vol.30(6). P. 669-675.
Gordon S.M., LaRosa S.P., Kalmadi S. et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? // Clin Infect Dis 1999. Vol. 28. P. 240–246.
Gupta S., Dash S.C., Sharma S. et al. Pneumocystis carinii pneumonia: role of high resolution computed tomography // J Assoc Physicians India. 2002. Vol. 50(5). P. 726–728.
Hirsch H.H., Lautenschlager I., Pinsky B.A. et al. An international multicenter perfomance analysis of cytomegalovirus load tests // Clin Infect Dis. 2013. Vol. 56. P. 367.
Hirsh H.H., Rinaldo C.H., Drachenberg C.D. et al. Emergence of rearrangements in the BKV non-coding control region in renal transplant patients // Am J Transplant. 2006. Vol. 6 [S2]. P. 91.
Humar A., Limaye A.P., Blumberg E.A. et al. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study // Transplantation. 2010. Vol. 90. P. 1427.
Kamar N., Toupance O., Buchler M. et al. Evidence that clearance of hepatitis C virus RNA after alfa-interferon therapy in dialysis patients is sustained after renal transplantation. // J Am Soc Nephrol. 2003. Vol. 14. P. 2092–2098.
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients // Am J Transplant 2009. Vol. 9(Suppl 3). S1–S157.
KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in Chronic Kidney Disease: Managemant of HCV-infected patients before and after kidney transplantation // Kidney Int. 2008. Vol. 73. S53-68.
Kotton C.N., Kumar D., Caliendo A.M. et al. Updated international consensus guidelines on the managament of cytomegalovirus in solid-organ transplantation // Transplantation. 2013. Vol. 96. P. 333-360.
Mannon R.B., Hoffman S.C., Kampen R.L. Molecular evaluation of BK polyomavirus nephropathy // Am J Transplant. 2005. Vol. 5. P. 2883-2893.
Munoz P. Management of urinary tract infections and lymphocele in renal transplant recipients // Clin Infect Dis. 2001. Vol. 33(Suppl 1). S53–57.
Naqvi R., Akhtar S., Noor H. et al. Efficacy of isoniazid prophylaxis in renal allograft recipients // Transplant Proc. 2006. Vol. 38. P. 2057–2058.
Park S.K., Yang W.S., Lee Y.S. et al. Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine // Nephrol Dial Transplant. 2001. Vol. 11. P. 2222-2228.
Prelog M., Pohl M., Ermisch B. et al. Demand for evaluation of vaccination antibody titers in children considered for renal transplantation // Pediatr Transplant. 2007. Vol. 11. P. 73-76.
Radisic M., Lattes R., Chapman J.F. et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study // Transpl Infect Dis. 2003. Vol. 5(2). P. 84–93.
Ram R., Swarnalatha G., Prasad N., Dakshinamurty K.V. Tuberculosis in renal transplant recipients // Transplant Infect Dis. 2007. Vol. 9. P. 97-101.
Rao K.V., Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients // Transplantation. 1996. Vol. 11. P. 1765-1769.
Rollag H., Sagedal S., Kristiansen K.I. et al. Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients // Clin Microbiol Infect. 2002. №8. P. 431-438.
Rose D.N. Benefits of screening for latent Mycobacterium tuberculosis infection // Arch Intern Med. 2000. Vol. 160. P. 1513 – 1521.
Rostaing L., Wéclawiak H., Mengelle C., Kamar N. Viral infections after kidney transplantation // Minerva Urol Nefrol. 2011. Vol. 63(1). P. 59-71.
Schmaldienst S., Dittrich E., Horl W.H. Urinary tract infections after renal transplantation // Curr Opin Urol. 2002. Vol. 12. P. 125–130.
Tolkoff-Rubin N.E., Rubin R.H. Recent advances in the diagnosis and management of infection in the organ transplant recipient // Semin Nephrol. 2000. Vol. 2. P. 148-163.
|